Clinical trial
A Phase I, Open-Label, Randomized, Crossover Trial to Investigate the Relative Bioavailability of the 25 mg Dapivirine Vaginal Ring-004 Inserted Every 30 Days and 100 mg DPV Ring-008 Inserted for 90 Days in Healthy Female Participants
NCT05416021 is registered in ClinicalTrials.gov with International Partnership for Microbicides, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I, Open-Label, Randomized, Crossover Trial to Investigate the Relative Bioavailability of the 25 mg Dapivirine Vaginal Ring-004 Inserted Every 30 Days and 100 mg DPV Ring-008 Inserted for 90 Days in Healthy Female Participants
- Lead sponsor
- International Partnership for Microbicides, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 1, 2022
- Completion date
- July 2, 2024
- Enrollment
- 124 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.